Adagio Medical Holdings, Inc.
Revenue breakdown: Single Reportable Segment (100%).
8-K
Adagio Medical Holdings, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2025, reporting a net loss of $3.3 million for Q4 2025 and $25.1 million for the full year, alongside key business updates including the completion of enrollment in its FULCRUM-VT pivotal trial and a private placement raising up to $50 million.